News

Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.

The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.

bit.bio Chief Operating Officer Kathryn Corzo featured in Endpoints News.

bit.bio appoints accomplished biotechnology executive and drug developer Kathryn Corzo as Chief Operating Officer.

The pledge is part of our mission to code cells for novel cures and to be a purpose led company.

This feature covers the latest fundraise and appointments to the board.

Funding raised to accelerate and expand cell therapy pipeline.

bit.bio adds $100M+ to its coffers and some impressive names to its board of directors.